drugset / Trial / NCT00002386

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

NCT00002386

Phase 4 Completed 55 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see if indinavir plus two other anti-HIV drugs affect blood clotting in HIV-positive patients with hemophilia.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Didanosine Small molecule
Subject INDINAVIR ANHYDROUS Other / unclassified
Subject Lamivudine Other / unclassified
Subject Stavudine Other / unclassified
Subject Zalcitabine Small molecule
Subject Zidovudine Small molecule